Cogent Biosciences Inc (COGT)
Healthcare
Biotechnology
38.90 $
-5.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Cogent Biosciences Inc (COGT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.1% of the shares are freely tradable; institutional investors hold 112.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
112.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
94.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
171Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 13.53 | 23,122,748 | +0.2 | 03/31/2026 |
| BlackRock Inc | 9.39 | 16,045,014 | +23.7 | 03/31/2026 |
| Vanguard Group Inc | 6.74 | 11,514,326 | +48.4 | 12/31/2025 |
| Deerfield Management Co | 5.29 | 9,043,903 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.29 | 7,333,333 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.04 | 6,894,959 | +0.0 | 03/31/2026 |
| HHG PLC | 3.49 | 5,965,125 | +31.5 | 03/31/2026 |
| State Street Corp | 3.31 | 5,663,543 | +14.6 | 03/31/2026 |
| Fairmount Funds Management LLC | 3.22 | 5,503,418 | -38.9 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 3.19 | 5,458,675 | -28.1 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.